Skip to main content
. 2024 Jun 3;42(23):2747–2756. doi: 10.1200/JCO.24.00708

FIG 2.

FIG 2.

Survival analysis. (A) Intracranial PFS as per RECIST assessed by investigator and (B) OS from full analysis set. (C) Intracranial PFS as per RANO-LM criteria assessed by BICR and (D) OS from LM evaluable for response set. BICR, blinded independent central review; LM, leptomeningeal metastases; OS, overall survival; PFS, progression-free survival; RANO-LM, response assessment in neuro-oncology leptomeningeal metastases.